Skip to main content
Premium Trial:

Request an Annual Quote

Sophic to Use $1.3M NCI Funds with Biomax for Cancer Database

NEW YORK (GenomeWeb News) – The life sciences software company Sophic said today it will use $1.3 million from the National Cancer Institute over one year to complete an index of a total of 6,610 cancer-related genes that are found in Medline abstracts.
 
Sophic said it built the standardized and curated cancer database over the past four years through a collaboration with NCI and with the German company Biomax Informatics. The collaboration has already resulted in a compendium of 4,658 annotated cancer genes that are now available through the NCI’s website, the company said.
 
"This knowledge base is the foundation for reliable, accurate cancer research for all types of cancer diseases, clinical trials, biomarkers and much more,” said Sophic CEO Pat Blake.
 
Biomax CEO Kleus Heumann said the collaborators used a “factory assembly line" approach “that allows the automated text mining results to be fed to the scientific team who curate and annotate the information in an efficient, quality-controlled, work-flow process.”

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.